Alkermes plc Reports First Quarter 2023 Financial Results :

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today reported financial results for the first quarter of 2023....

Related Keywords

Ohio , United States , Athlone , Westmeath , Ireland , Massachusetts , Waltham , Dublin , Iain Brown , Katie Joyce , Sandy Coombs , Exchange Commission , Johnson , Alkermes Inc , Nasdaq , Biogen Ma Inc , Alkermes , Drug Administration , Alkermes Pharma Ireland , First Quarter Revenues , Reflect Strong Performance , Proprietary Product Portfolio , Planned Separation , Oncology Business Expected , Second Half , Second Favorable Interim Award Received , Janssen Arbitration , Financial Expectations , Richard Pops , Chief Executive Officer , Chief Financial Officer , Ended March , Goods Manufactured , United States Securities , Mural Oncology , Second Interim Award , Know How Royalty , Private Securities Litigation Reform Act , Annual Report , Alkermes Pharma Ireland Limited , Financial Information , Consolidated Statements , Months Ended , Earnings Per Share , Average Number , Ordinary Shares Outstanding , Quarterly Report , Alkermes Plc ,